Patent Foramen Ovale Management for Secondary Stroke Prevention: State-of-the-Art Appraisal of Current Evidence
Stroke · 2024-01 · 55 (1) · 236-247
DOI: 10.1161/strokeaha.123.040546 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stroke, 2024-01. Verfasst von Luciano A Sposato und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Clinical Neurological Sciences, Epidemiology and Biostatistics, and Anatomy and Cell Biology, Schulich School of Medicine and Dentistr…. Hauptthemen laut MEDLINE: Foramen Ovale, Patent, Stroke, Ischemic Stroke. Die Arbeit wurde bisher 109-mal zitiert (Crossref) und nennt 59 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Patent foramen ovale (PFO) is frequently identified in young patients with ischemic stroke. Randomized controlled trials provide robust evidence supporting PFO closure in selected patients with cryptogenic ischemic stroke; however, several questions remain unanswered. This report summarizes current knowledge on the epidemiology of PFO-associated stroke, the role of PFO as a cause of stroke, and anatomic high-risk features. We also comment on breakthrough developments in patient selection algorithms for PFO closure in relation to the PFO-associated stroke causal likelihood risk stratification system. We further highlight areas for future research in PFO-associated stroke including the efficacy and safety of PFO closure in the elderly population, incidence, and long-term consequences of atrial fibrillation post-PFO closure, generalizability of the results of clinical trials in the real world, and the need for assessing the effect of neurocardiology teams on adherence to international recommendations. Other important knowledge gaps such as sex, race/ethnicity, and regional disparities in access to diagnostic technologies, PFO closure devices, and clinical outcomes in the real world are also discussed as priority research topics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departments of Clinical Neurological Sciences, Epidemiology and Biostatistics, and Anatomy and Cell Biology, Schulich School of Medicine and Dentistry (L.A.S.), Western University, London, ON, Canada.
- Heart & Brain Laboratory (L.A.S.), Western University, London, ON, Canada.
- Robarts Research Institute and Lawson Health Research Institute, London, ON, Canada (L.A.S.).
- Department of Neurology & Neurosurgery, Emory University School of Medicine, Atlanta, GA (C.S.W.A.).
- Department of Neurology, Vagelos College of Physicians and Surgeons (M.S.V.E.), Columbia University, New York.
- Department of Epidemiology, Mailman School of Public Health (M.S.V.E.), Columbia University, New York.
ORCID-Profile: Luciano A Sposato, Mitchell S V Elkind, Hooman Kamel, Jeffrey L Saver
Zitieren
APA
Sposato, L. A., Albin, C. S. W., Elkind, M. S. V., Kamel, H., & Saver, J. L. (2024). Patent Foramen Ovale Management for Secondary Stroke Prevention: State-of-the-Art Appraisal of Current Evidence. Stroke, 55(1), 236-247. https://doi.org/10.1161/strokeaha.123.040546
Vancouver
Sposato LA, Albin CSW, Elkind MSV, Kamel H, Saver JL. Patent Foramen Ovale Management for Secondary Stroke Prevention: State-of-the-Art Appraisal of Current Evidence. Stroke. 2024;55(1):236-247. doi:10.1161/strokeaha.123.040546
BibTeX
@article{Sposato2024,
author = {Sposato, Luciano A and Albin, Catherine S W and Elkind, Mitchell S V and Kamel, Hooman and Saver, Jeffrey L},
title = {Patent Foramen Ovale Management for Secondary Stroke Prevention: State-of-the-Art Appraisal of Current Evidence},
journal = {Stroke},
year = {2024},
volume = {55},
number = {1},
pages = {236--247},
doi = {10.1161/strokeaha.123.040546}
}
EUVIMED